NEWSTEM
NewStem is a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy's effectiveness. NewStem is a spinoff of Yissum, The Technology Transfer Company of The Hebrew University. NewStem's technology can predict patients' resistance to chemotherapy allowing for better, targeted cancer treatments and the potential to reduce resistance to chemotherapy.
NEWSTEM
Social Links:
Industry:
Biopharma Biotechnology Life Science
Founded:
2016-09-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.newstem.com
Total Employee:
1+
Status:
Active
Total Funding:
4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Organization Schema Google Maps
Current Employees Featured
Founder
Investors List
Illumina Accelerator
Illumina Accelerator investment in Seed Round - NewStem
Hollywood Media Corp.
Hollywood Media Corp. investment in Seed Round - NewStem
Official Site Inspections
http://www.newstem.com
- Host name: box5754.bluehost.com
- IP address: 162.241.253.12
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "NewStem"
NewStem - Crunchbase Company Profile & Funding
NewStem is a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy's effectiveness. NewStem is a spinoff of Yissum, The Technology …See details»
NewStem Biotechnologies - Crunchbase Company Profile & Funding
Organization. NewStem Biotechnologies . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. NewStem Biotechnologies uses somatic cell transfer for …See details»
NewStem | NovelStem
NewStem is currently the only company worldwide to develop products based on this innovative, paradigm-changing proprietary technology. NewStem possesses pioneering intellectual property, reagents and experience related to the …See details»
Newstem Biotechnologies, Inc. - VentureRadar
NewStem is a biopharmaceutical company focused on human Pluripotent Stem Cells (hPSCs) in general, and Haploid human Pluripotent Stem Cells (HhPSCs), in particular. These cells have …See details»
NewStem 2025 Company Profile: Valuation, Funding & Investors
NewStem General Information Description. Operator of a biopharmaceutical company intended to increase chemotherapy's effectiveness. The company utilizes a platform for the discovery and …See details»
NewStem Ltd. Overview | SignalHire Company Profile
Organization Website: newstem.com : NewStem Ltd. industries Biotech: Headquarters Location: The Hebrew University of Jerusalem Edmond J. Safra Campus, Givat Ram, Israel, 91904 IL …See details»
NewStem - Funding, Financials, Valuation & Investors - Crunchbase
NewStem is a biotechnology startup company a spin-off of Yissum. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. Experience the new …See details»
NewStem Ltd. - Org Chart, Teams, Culture & Jobs - The Org
View NewStem Ltd.'s up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
NewStem Company Profile - Office Locations, Competitors ... - Craft
NewStem is a biopharmaceutical company that specializes in human haploid pluripotent stem cells (HHPSCs). The pluripotent stem cell characteristics enable the differentiation into other …See details»
NEWSTEM BIOTECHNOLOGIES INC - Dun & Bradstreet
Newstem biotechnologies inc. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united states …See details»
NewStem Ltd. - Biotech company in Israel - F6S Companies
NewStem Ltd. Presents Haploid Human Embryonic Stem Cells. NewStem Ltd. founders & employees. Ayelet Dilion Mashiah. Jerusalem, Israel. CEO @NewStem Ltd. Find out more …See details»
NewStem - Israeli Startup | Startup Nation Finder
Apr 21, 2020 NewStem has developed a novel technology for predicting resistance to anticancer treatments. The company is creating a diagnostic tool based on pioneering research in the …See details»
NewStem - Contacts, Employees, Board Members, Advisors
NewStem is a biotechnology startup company a spin-off of Yissum. Start Free TrialSee details»
NovelStem Announces NewStem, Ltd. was Selected by Illumina for …
Sep 20, 2021 NewStem’s diagnostic technology is based on the research of specialized stem cells that carry just one set of chromosomes (haploid cells) by Professor Nissim Benvenisty, …See details»
Hollywood Media Completes Transformational Investment in …
Jul 16, 2018 Jerusalem, Israel and Boca Raton, FL, July 16, 2018 - Hollywood Media Corp. (OTC Pink: HOLL) (HMC) today announced the strategic transformation of the Company, its …See details»
NovelStem Increases NewStem Ownership to 33% as NewStem …
Dec 1, 2020 BOCA RATON, Fla. and JERUSALEM, Dec. 01, 2020 (GLOBE NEWSWIRE) -- NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on its …See details»
NovelStem Now an SEC-Reporting Company, Secures …
Boca Raton, FL, October 13, 2022 – NovelStem International Corp. (OTC Pink: NSTM), a development-stage company focused on the stem cell-based technology platform developed …See details»
NewStem - Updates, News, Events, Signals & Triggers - Crunchbase
NewStem is a biotechnology startup company a spin-off of Yissum. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. Experience the new …See details»
NewStem Files FDA Pre-Submission and EMA IVDD for …
Apr 11, 2022 NewStem is the only company worldwide to develop therapeutics and diagnostics products based on haploid human embryonic stem cell research. JERUSALEM, April 11, 2022 …See details»
“Some hard and important lessons”: One of the most promising …
22 hours ago National Trust for Local News co-founder Elizabeth Hansen Shapiro has led the organization through its four-year growth spurt. The Trust has raised $37 million with Hansen …See details»